Filter
715
Text search:
Good
Manufacturing
Practices
Featured
Recommendations
57
New Publications
194
Language
Document type
No document type
368
Studies & Reports
137
Guidelines
108
Strategic & Response Plan
43
Manuals
33
Fact sheets
9
Training Material
8
Situation Updates
6
Brochures
1
Resource Platforms
1
Videos
1
Countries / Regions
Kenya
34
India
33
Global
25
Uganda
20
Ghana
19
Nigeria
18
Ethiopia
18
Western and Central Europe
16
Sierra Leone
15
Zambia
13
South Africa
13
Nepal
12
Tanzania
12
Liberia
10
Rwanda
10
Africa
10
Philippines
9
South–East Asia Region
8
Zimbabwe
7
Bangladesh
7
Malawi
7
Namibia
7
Ukraine
7
Myanmar / Burma
7
Guinea
6
Indonesia
6
Botswana
5
Lesotho
5
Asia
5
Congo, Democratic Republic of
4
Haiti
4
Syria
4
Cambodia
4
Eswatini/ Swaziland
4
East and Southern Africa
4
West and Central Africa
4
Latin America and the Carribbean
4
Eastern Europe
4
South Sudan
3
Eastern Europe and Central Asia
3
Senegal
2
USA
2
Cameroon
2
Pakistan
2
Thailand
2
Sudan
2
Sri Lanka
2
Middle East and North Africa
2
Western Pacific Region
2
Albania
2
Laos
2
Tajikistan
2
Moldova
2
Mauritius
2
Afghanistan
1
Turkey
1
China
1
Benin
1
Colombia
1
Ecuador
1
Venezuela
1
Russia
1
Australia
1
Turkmenistan
1
Maldives
1
United Kingdom
1
Authors & Publishers
Publication Years
Category
Countries
279
Key Resources
42
Public Health
39
Clinical Guidelines
37
Pharmacy & Technologies
27
Women & Child Health
18
Capacity Building
7
Toolboxes
Pharmacy
69
AMR
62
COVID-19
55
HIV
42
Planetary Health
40
TB
22
Rapid Response
19
Mental Health
19
Ebola
16
Global Health Education
14
Disability
13
Conflict
13
Specific Hazards
11
NCDs
11
Natural Hazards
10
NTDs
8
Health Financing Toolbox
8
Refugee
7
Caregiver
5
Cholera
4
Polio
3
Zika
2
This document outlines the working structure and guiding principles for collaboration of COVAX, the Vaccines pillar of the Access to COVID-19 Tools Accelerator (ACT-A). The working structure of COVAX continues to adapt to emerging needs and the changing trajectory of the pandemic. Some components of
...
Report of the WHO/Bill & Melinda Gates Foundation Consultation. The Consultation was organized back-to-back with the first annual meeting of the International Coordinating Group of the BMGF-funded project for human and dog rabies elimination in developing countries, held at WHO headquarters, Geneva,
...
Climate change presents the single biggest threat to human development, and its widespread impacts disproportionately burden the poorest and most vulnerable households in fragile and rural developing contexts – particularly women and children.
According to the Intergovernmental Panel on Climate C
...
Promoting health and preventing disease is a critical component of the effort required to achieve Universal Health Coverage (UHC). to date, efforts to achieve UHC have focused mostly on strengthening health systems and their capacities to provide curative care. However, experience from the COVID-19
...
The report aims to capture lessons from the COVID-19 pandemic and to highlight the opportunity for more ambitious global action: expanding sustainable access to vaccines for all towards the Immunization Agenda 2030 and pandemic prevention, preparedness and response efforts. The report is organized i
...
Around the world, more than 2 billion people lack access to safely managed water, sanitation and hygiene services, with conflicts and climate change exacerbating the issue.
Unsafe and insufficient WASH facilities, especially in rural and remote areas, can lead to increased health complications fo
...
Air pollution is one of the leading causes of health complications and mortality worldwide, especially affecting lower-income groups, who tend to be more exposed and vulnerable. This study documents the relationship between ambient air pollution exposure and poverty in 211 countries and territories.
...
HIV testing programmes need to ensure that all clients who test for HIV are provided with correct diagnoses. The accuracy of HIV testing is critical to prevent misdiagnosis, as the consequences of giving an incorrect test result can be serious for clients, HIV testing services, HIV programmes and pu
...
• provide scientific information on the safety, efficacy, and quality control/ quality assurance of widely used medicinal plants, in order to facilitate their appropriate use in Member States;
• provide models to assist Member States in developing their own mono- graphs or formularies for these
...
Revised Edition
Examination of the business behaviour of Boehringer Ingelheim, Bayer and Baxter in Uganda
